Author

Bradley M. Miller

Institution: Eli Lilly (United States)

Observed institutions: Eli Lilly (United States), University of Virginia

OpenAlex ID: A5113826328

Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem

2017 · Stephen P. Arnerić, Jesse M. Cedarbaum, et al. · Nature Reviews Drug Discovery · 41

Manipulation of the mitochondrial genome to improve bioenergetics in human childhood disease models

2011 · Shilpa Iyer⁎, Kristen E. Berquist, et al. · Mitochondrion

Works count: 2

Citation count: 41

H-index: 1

I10-index: 1